. Erratum: Postoperative Adjuvant Anastrozole for 10 or 5 Years in Patients With Hormone Receptor-Positive Breast Cancer: AERAS, a Randomized Multicenter Open-Label Phase III Trial. J Clin Oncol 2023 Jun 26:JCO2301230. doi: 10.1200/JCO.23.01230.
PMID: 37364217